MPH Health Care

Earnings Release • Mar 8, 2013

News Details

Corporate | 8 March 2013 11:21

MPH Mittelständische Pharma Holding AG: Preliminary IFRS results 2012, sales of EUR 205 million, annual net income of EUR 17 million

MPH Mittelständische Pharma Holding AG / Key word(s): Preliminary Results/Final Results

08.03.2013 / 11:21

---

Preliminary IFRS results 2012, sales of EUR 205 million, annual net income of EUR 17 million

Berlin, March, 8, 2013

MPH Mittelständische Pharma Holding AG, Berlin (ISIN: DE000A0NF697), today reports its preliminary IFRS Group results for the financial year 2012.

In the financial year 2012, the preliminary IFRS sales amounted to approximately EUR 205 million and the preliminary IFRS consolidated profit grew to about EUR 17 million. The preliminary IFRS earnings per share reached about EUR 0.4.

IFRS Group sales increased by over 40 %, from EUR 145.51 million to around EUR 205 million compared to the previous year 2011. IFRS consolidated profit rose by 96 % from EUR 8.65 million to about EUR 17 million.

The Management Board will propose the dividend amount to the Supervisory Board and the shareholders after the final numbers 2012 have been established.

'The MPH Group will further expand the segments Pharma and Healthcare in year 2013. The business success in year 2012 will enable the Group to carry on with the shareholder-friendly dividend policy', said Patrick Brenske and Dr. Christian Pahl, Members of the Management Board of MPH Mittelständische Pharma Holding AG.

About MPH Mittelständische Pharma Holding AG:

The company MPH Mittelständische Pharma Holding AG, based in Berlin, has strategically concentrated its activities on the growth segments Pharma and Healthcare. On the basis of patent-free and patent-protected active substances, production and consultancy services for therapies of chronic diseases, the Group makes a precious contribution to keeping health affordable.

MPH Mittelständische Pharma Holding AG is listed in the Entry Standard (Open Market) of the Frankfurt stock exchange.

Key figures for the share of MPH Mittelständische Pharma Holding AG:

Subscribed capital: EUR 41.167.155

Listed shares: Preference shares

Number of preference shares in circulation: 19.025.000

ISIN: DE000A0NF697

WKN: A0NF69

Stock symbol: 93MV

Contact:

Linda Reichelt

MPH Mittelständische Pharma Holding AG

Hubertusallee 73

D-14193 Berlin

Tel:+49 (0) 30 897308660 Fax:+49 (0) 30 897308670

E-Mail: ir@mph-ag.de Web: www.mph-ag.de

End of Corporate News

---

08.03.2013 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG.

The issuer is solely responsible for the content of this announcement.

DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language:	English
Company:	MPH Mittelständische Pharma Holding AG
	Hubertusallee 73
	14193 Berlin
	Germany
Phone:	030 / 897 308 660
Fax:	030 / 897 308 670
E-mail:	info@mph-ag.de
Internet:	www.mph-ag.de
ISIN:	DE000A0NF697
WKN:	A0NF69
Listed:	Freiverkehr in Berlin, Düsseldorf, Stuttgart; Frankfurt in Open Market (Entry Standard)

End of News	DGAP News-Service

- - -
203409  08.03.2013